Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,371,784
  • Shares Outstanding, K 211,480
  • Annual Sales, $ 11,449 M
  • Annual Income, $ 3,703 M
  • 36-Month Beta 0.73
  • Price/Sales 6.02
  • Price/Cash Flow 13.78
  • Price/Book 5.36

Price Performance

See More
Period Period Low Period High Performance
1-Month
306.11 +6.00%
on 11/21/17
330.61 -1.85%
on 12/11/17
+14.04 (+4.52%)
since 11/10/17
3-Month
301.81 +7.51%
on 10/24/17
348.84 -6.98%
on 10/18/17
-5.21 (-1.58%)
since 09/12/17
52-Week
244.28 +32.83%
on 05/31/17
348.84 -6.98%
on 10/18/17
+60.59 (+22.96%)
since 12/12/16

Most Recent Stories

More News
Biogen to Present at the Guggenheim 5th Annual Healthcare Conference

Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the Guggenheim 5th Annual Healthcare Conference. The webcast will be live on Wednesday, December 13, 2017 at 12:00...

BIIB : 324.49 (-1.08%)
Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data

Data presentations and regulatory updates were the key highlights this week with companies like AbbVie (ABBV) and Clovis providing data on their pipeline candidates.

RARE : 45.12 (-0.27%)
CLVS : 63.43 (+0.84%)
ABBV : 94.98 (-1.54%)
REGN : 377.31 (-1.05%)
AMGN : 174.34 (-1.41%)
BIIB : 324.49 (-1.08%)
RVNC : 35.50 (-1.25%)
Biogen Appoints Mark Hernon as SVP, Chief Information Officer

Biogen (NASDAQ: BIIB) announced today the appointment of Mark Hernon as Senior Vice President, Chief Information Officer, effective December 4.

BIIB : 324.49 (-1.08%)
The Zacks Analyst Blog Highlights: Amazon, AbbVie, Biogen, McCormick and Hyatt

The Zacks Analyst Blog Highlights: Amazon, AbbVie, Biogen, McCormick and Hyatt

MKC : 101.53 (+1.00%)
H : 70.89 (-1.40%)
ABBV : 94.98 (-1.54%)
AMZN : 1,170.97 (+0.18%)
BIIB : 324.49 (-1.08%)
Biogen Acquires Worldwide License for Alkermes' MS Candidate (revised)

The deal will be beneficial for both companies as it will reduce costs and bring in a strong partner for Alkermes.

LGND : 136.36 (+0.96%)
RHHBY : 30.3100 (+0.17%)
ALKS : 52.13 (-0.06%)
BIIB : 324.49 (-1.08%)
Top Research Reports for Amazon, AbbVie & Biogen

Top Research Reports for Amazon, AbbVie & Biogen

MKC : 101.53 (+1.00%)
HP : 59.30 (+1.47%)
H : 70.89 (-1.40%)
ABBV : 94.98 (-1.54%)
AMZN : 1,170.97 (+0.18%)
BIIB : 324.49 (-1.08%)
Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal

While there were not too many updates this week, companies like Regeneron (REGN) and Biogen were in the news related to their pipeline.

CTMX : 21.08 (-0.14%)
REGN : 377.31 (-1.05%)
CPRX : 4.23 (+0.71%)
ALKS : 52.13 (-0.06%)
AMGN : 174.34 (-1.41%)
BIIB : 324.49 (-1.08%)
Recent Analysis Shows Aflac, Biogen, Oasis Petroleum, Twilio, Neothetics, and McDonald's Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aflac Incorporated (NYSE:AFL),...

OAS : 8.85 (-12.03%)
TWLO : 25.31 (+1.97%)
AFL : 88.55 (+0.08%)
NEOT : 1.48 (-1.33%)
BIIB : 324.49 (-1.08%)
MCD : 172.17 (-0.62%)
Biogen Acquires Worldwide License for Alkermes' MS Candidate

Biogen (BIIB) and Alkermes clinch collaboration agreement to develop and commercialize Alkermes' multiple sclerosis candidate, ALKS8700.

LGND : 136.36 (+0.96%)
RHHBY : 30.3100 (+0.17%)
ALKS : 52.13 (-0.06%)
BIIB : 324.49 (-1.08%)
Today's Research Reports on Stocks to Watch: Biogen and Teva Pharmaceutical

NEW YORK, NY / ACCESSWIRE / November 28, 2017 / Israeli-based Teva (NYSE: TEVA) saw big gains on Monday after the company announced it would be revealing a detailed restructuring plan next month. This...

TEVA : 16.60 (+0.97%)
ALKS : 52.13 (-0.06%)
BIIB : 324.49 (-1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

2nd Resistance Point 335.05
1st Resistance Point 331.54
Last Price 324.49
1st Support Level 323.59
2nd Support Level 319.15

See More

52-Week High 348.84
Last Price 324.49
Fibonacci 61.8% 308.90
Fibonacci 50% 296.56
Fibonacci 38.2% 284.22
52-Week Low 244.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.